已收盘 10-16 16:00:00 美东时间
+0.020
+0.17%
Barclays analyst Richard Hightower maintains RLJ Lodging Trust (NYSE:RLJ) with a Underweight and raises the price target from $11 to $12.
10-14 00:29
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Deutsche Bank analyst Steve Powers downgraded PepsiCo Inc (NASDAQ:PEP) from Buy to Hold and cut t...
09-29 01:47
Strength in third-quarter RevPAR across the lodging REIT sector and expectations for continued growth prompted Raymond James analyst RJ Milligan to upgrade Park Hotels & Resorts (PK) to Strong Buy fro...
09-28 21:55
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25
Truist Securities analyst Gregory Miller maintains RLJ Lodging Trust (NYSE:RLJ) with a Hold and raises the price target from $10 to $11.
09-21 21:09
RLJ Lodging Trust (RLJ) declares $0.15/share quarterly dividend, in line with previous. Forward yield 5.49% Payable Oct. 15; for shareholders of record Sept. 30; ex-div Sept. 30. See RLJ Dividend Scor...
09-15 20:12
今日重点评级关注:Ascendiant Capital:维持PAVmed"买入"评级,目标价从56美元升至57美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9.25美元升至9.5美元
08-28 16:15
Barclays analyst Richard Hightower maintains RLJ Lodging Trust (NYSE:RLJ) with a Underweight and raises the price target from $9.5 to $11.
08-27 23:24
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45